Observational studyInternational journal of obesity (2005)2025
The long-term effect of metabolic bariatric surgery on innate immune cell phenotype and function.
Observational study in International journal of obesity (2005), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Bariatric surgery and subsequent weight loss lead to a reversal of peripheral blood monocytosis in obesity.International journal of obesity (2005) · 2026Article
- NLRP3-Caspase-1 Axis in Human Adipose Tissue Crown-Like Structures: A Potential Mediator of Inflammation and the Effects of Bariatric Surgery.Immunity, inflammation and disease · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesObesity is an important risk factor for atherosclerotic cardiovascular disease. This cardiovascular risk remains increased even after substantial weight loss by bariatric surgery. Innate immune cells are important regulators of atherogenesis and can adopt a long-term hyperinflammatory phenotype via epigenetic reprogramming, called "trained immunity". In this translational observational case-cohort study, we investigated the persistence of innate immune cell hyperresponsiveness following bariatric surgery, and explored the potential contribution of adipose tissue in ex vivo models. SUBJECTS/
methodsIn a cohort of 27 patients with obesity blood was drawn before and six months after bariatric surgery, and compared to 20 healthy subjects with normal body weight. We assessed monocytes using flow cytometry, functional assays, and RNA sequencing and chromatin immunoprecipitation. In an accompanying series of in vitro studies, healthy donor monocytes were exposed for 24 h to adipose tissue obtained from patients with obesity during bariatric surgery. Cytokine production capacity was assessed after one week.
resultsIn our case-cohort study, although leukocyte numbers and systemic inflammatory markers such as hs-CRP decreased after bariatric surgery to the level of normal weight control subjects, the hyperresponsive pro-inflammatory monocyte phenotype was only partially reverted six months after bariatric surgery, which aligned with the RNA expression profiles. Exposure of monocytes to adipose tissue obtained from patients with obesity induces a persistent augmented cytokine production capacity.
conclusionsAlthough in patients with obesity, six months after bariatric surgery systemic inflammatory markers and leukocyte numbers are decreased to the levels observed in healthy lean subjects, there is still a residual functional and transcriptional hyper-inflammatory monocyte phenotype. This might be caused, at least in part, by the capacity of adipose tissue to induce long-term pro-inflammatory effects in monocytes. These finding help to understand the long-term effects of obesity and bariatric surgery on cardiovascular health.
Indexed as
Identifiers
40836110What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.